Skip to main content
. Author manuscript; available in PMC: 2013 May 15.
Published in final edited form as: AIDS. 2012 May 15;26(8):987–995. doi: 10.1097/QAD.0b013e3283522d47

Figure 3. Two-way sensitivity analysis of TB prevalence and mortality of untreated TB on the incremental cost-effectiveness ratio (ICER) for Xpert.

Figure 3

The lower horizontal line indicates the 2010 per capita GDP of South Africa ($7,100), which the WHO defines as ‘very cost-effective’ (see Methods). The upper horizontal line indicates three times the per capita GDP of South Africa ($21,300), which is considered a ‘cost-effective’ intervention.